Mucoadhesive and muco-penetrating delivery systems for eradication of Helicobacter pylori

@article{Arora2012MucoadhesiveAM,
  title={Mucoadhesive and muco-penetrating delivery systems for eradication of Helicobacter pylori},
  author={Saahil Arora and Gaurav Bisen and R. D. Budhiraja},
  journal={Asian Journal of Pharmaceutics},
  year={2012},
  volume={6},
  pages={18}
}
Helicobacter pylori (H. pylori), the major culprit for peptic ulcer, has a unique way of survival in harsh acidic environment of the stomach by colonizing deep in the gastric mucosal layer. Failure of conventional therapies against H. pylori for complete eradication has major limitations like low residence time of delivery system in stomach, poor penetration of drug in gastric mucosa, acidic degradation of antibiotics, and development of antibiotics resistance. The poor penetration of… 
View via Publisher
asiapharmaceutics.info
17 Citations
Background Citations
5

Figures and Tables from this paper

17 Citations

The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection
TLDR
A brief description of the use of chitosan in H. pylori treatment is reviewed and it is proposed that chitOSan can also be used for H.pylori binding and scavenging from the host stomach due to its antimicrobial/binding properties.
An overview of nanotechnology-based treatment approaches against Helicobacter Pylori
TLDR
An overview of the current limitations and new promising altenatives in treatment of H.Pylori is provided, to highlight the location of nanotechnology to overcome treatment failures, and to emphasize the advantages of using membrane-coated nanoparticles for the first time.
The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications
TLDR
A survey of current curative options based on polypharmacy, looking at pharmacokinetics, pharmacodynamics and pharmaceutical microbiology concepts, in the battle against H. pylori infection is provided.
Modification of drug delivery to improve antibiotic targeting to the stomach.
TLDR
This review summarizes the current research in the development of gastroretentive formulations and the prospective future applications of this approach in the targeted delivery of drugs such as antibiotics to the stomach.
Design of enzyme decorated mucopermeating nanocarriers for eradication of H. pylori infection
TLDR
Amoxicillin loaded papain modified thiolated polycarbophil nanocarrier system was able to completely eradicate H. pylori infection that was attributed to its enhanced mucopermeating and mucoadhesive nature and showed an interesting future potential for infectious therapy.
Formulation and advantages of furazolidone in liposomal drug delivery systems.
  • M. Alam, T. Paget, A. Elkordy
  • Biology
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2016
Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori.
In Vitro Intestinal Uptake And Permeability Of Fluorescently-Labelled Hyaluronic Acid Nanogels
TLDR
The HyA nanogels demonstrated to be mucoadhesive and effectively uptaken by intestinal cells and both are determinant features for sustained release, but if systemic delivery is envisaged further modification with targeting moieties could be important to improve the nanogel permeability.
FORMULATION AND IN-VITRO EVALUATION OF METRONIDAZOLE LOADED HPMC K15M MUCOADHESIVE MICROCAPSULES FOR H. PYLORI INFECTION USING 3
TLDR
The study shows that metronidazole mucoadhesive microcapsules can be effectively used for sustained drug release to the gastric mucosa in the treatment of H. pylori infection.
Famotidine microspheres reconstituted with floating in situ gel for stomach-specific delivery: Preparation and characterization
...
...

References

SHOWING 1-10 OF 97 REFERENCES
Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection.
TLDR
The newly developed composite nanocapsules along with the use of combination therapy proved to have commendable potential in Helicobacter pylori eradication as compared to already existing conventional and novel drug delivery systems.
Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori
TLDR
The floating microspheres more effectively cleared H. pylori from the GI tract than the drug because of the prolonged gastric residence time resulting from the excellent buoyancy of the PC.
Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori.
TLDR
The modified gelatin microsphere proves to be a possible candidate delivery system for the effective eradication of H. pylori and the gastric mucoadhesive properties of the microspheres were evaluated using RITC-labeled micro spheres in an isolated rat stomach.
Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.
Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
TLDR
The results indicate that hydrogels are pH-sensitive, leading to protecting nanoparticles from being destructed by gastric acid, and the incorporation of amoxicillin-loaded nanoparticles in a hydrogel protected the drug from the actions of the gastric juice and facilitated am toxicillin interaction specifically with intercellular spaces, the site of H. pylori infection.
Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.
Floating-Bioadhesive Microspheres Containing Acetohydroxamic Acid for Clearance of Helicobacter Pylori
TLDR
It is suggested that an oral dosage containing floating-bioadhesive microspheres may form a useful drug delivery system for the treatment of H. pylori.
Amoxicillin Loaded Chitosan–Alginate Polyelectrolyte Complex Nanoparticles as Mucopenetrating Delivery System for H. Pylori
TLDR
The optimised FITC labelled CS-ALG PEC nanoparticles have shown comparative low in-vitro mucoadhesion with respect to plain chitosan nanoparticles, but excellent mucopenetration and localization as observed with increased fluorescence in gastric mucosa continuously over 6 hours, which clinically can help in eradication of H. pylori.
Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori
The aim of the present study was to develop and characterize targeted sustained release nanoparticles of chitosan–glutamic acid conjugates containing triple therapy for Helicobacter pylori to improve…
Formulation and Evaluation of Gastroretentive Dosage Forms of Clarithromycin
TLDR
In vivo radiographic studies suggest that the tablet has increased gastric residence time for the effective localized action of the antibiotic (Clarithromycin) in the treatment of H.pylori mediated peptic ulcer.
...
...